Shinsuke Nakao

4PUBLICATIONS
8CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 25, 2025
Neutralizing monoclonal antibodies improve biodistribution of intravenously administered oncolytic adenovirus in human CD46-transgenic mice.

Masahisa Hemmi, Midori Yamashita, Yoshiko Shimizu

|Jan 08, 2025
A Multiple-Model-Informed Drug-Development Approach for Optimal Regimen Selection of an Oncolytic Virus in Combination With Pembrolizumab.

Akihiro Yamada, Mary P Choules, Frances A Brightman

|Apr 28, 2021
IL-7 coupled with IL-12 increases intratumoral T cell clonality, leading to complete regression of non-immunogenic tumors.

Mamoru Tasaki, Midori Yamashita, Yukinori Arai

|Jan 17, 2020
Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade.

Shinsuke Nakao, Yukinori Arai, Mamoru Tasaki

Pageof 1

Frequent Collaborators

2 joint publications

Midori Yamashita

1 joint publications

Ryuji Murakami

1 joint publications

Akihiro Yamada

1 joint publications

Mary P Choules